New Blood Pressure Target For Individuals at High Risk – American College of Cardiology
Elevated blood pressure is one of the strongest modifiable risk factors for the prevention of cardiovascular (CV) disease. The ESPRIT (Effects of Intensive Systolic Blood Pressure Lower Treatment in Reducing Risk of Vascular Events) trial was the largest randomized controlled trial investigating the CV outcomes of targeting systolic blood pressure (SBP) to < 120 mm Hg in individuals regardless of history of diabetes mellitus or stroke. Targeting SBP to < 120 mm Hg decreases CV events in individuals at
